Caspase 1

Target id: 1617

Nomenclature: Caspase 1

Family: C14: Caspase

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

   GtoImmuPdb view: OFF :     Currently no data for Caspase 1 in GtoImmuPdb

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 404 11q23 CASP1 caspase 1
Mouse - 402 9 A1 Casp1 caspase 1
Rat - 402 8q11 Casp1 caspase 1
Previous and Unofficial Names
ICE | IL-1 β-converting enzyme | p45 | interleukin 1 beta-converting enzyme | IL1BC | caspase 1, apoptosis-related cysteine peptidase
Database Links
Specialist databases
MEROPS C14.001 (Hs)
Other databases
BRENDA
ChEMBL Target
Ensembl Gene
Entrez Gene
GenitoUrinary Development Molecular Anatomy Project
Human Protein Atlas
KEGG Enzyme
KEGG Gene
OMIM
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Enzyme Reaction
EC Number: 3.4.22.36
Substrates and Reaction Kinetics
Substrate Sp. Property Value Units Standard property Standard value Assay description Assay conditions Comments Reference
Rho GDP dissociation inhibitor beta Hs - -
parkin Hs - -
pro-caspase 4 Hs - -
pro-interleukin-1β Hs - -

Download all structure-activity data for this target as a CSV file

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
VRT-043198 Hs Inhibition 9.1 pKi 4
pKi 9.1 (Ki 8x10-10 M) Derived from pro-drug belnacasan [4]
pralnacasan Hs Inhibition 9.0 pKi 3
pKi 9.0 (Ki 1x10-9 M) [3]
M826 Hs Inhibition 7.3 pIC50 2
pIC50 7.3 (IC50 5x10-8 M) [2]
Z-YVAD-FMK Hs Inhibition - - 1
[1]

References

Show »

1. Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz B. (2002) Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J. Nutr.132 (7): 1812-8. [PMID:12097652]

2. Han Y, Giroux A, Colucci J, Bayly CI, Mckay DJ, Roy S, Xanthoudakis S, Vaillancourt J, Rasper DM, Tam J et al.. (2005) Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg. Med. Chem. Lett.15 (4): 1173-80. [PMID:15686936]

3. Linton SD. (2005) Caspase inhibitors: a pharmaceutical industry perspective. Curr Top Med Chem5 (16): 1697-717. [PMID:16375749]

4. Wannamaker W, Davies R, Namchuk M, Pollard J, Ford P, Ku G, Decker C, Charifson P, Weber P, Germann UA et al.. (2007) (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J. Pharmacol. Exp. Ther.321 (2): 509-16. [PMID:17289835]

How to cite this page

C14: Caspase: Caspase 1. Last modified on 13/02/2016. Accessed on 24/10/2017. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1617.